GLP-1 RA Therapy for AUD
GLP-1 receptor agonist (GLP-1 RA) therapy is an innovative treatment for alcohol use disorder (AUD), initially designed for diabetes and obesity. This therapy can reduce alcohol consumption, decrease cravings, and improve metabolic health. However, it has challenges, including side effects, individual variability, and ethical concerns related to informed consent and off-label use. Community resource strategies … Read more